Peritoneal clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
CATALINA-2: a Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
open to eligible females ages 18 years and up
A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer.
at UCLA
Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
Sorry, in progress, not accepting new patients
This is a Phase 3, randomized, multinational, double-blind, dual placebo-controlled, 4-arm study evaluating rucaparib and nivolumab as maintenance treatment following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based on homologous recombination (HR) status of tumor samples.
at UCLA
Last updated: